A Brussels-based private group and arm of the Belgian CDC that seeks private damages for cartel victims in Europe – Cartel Damage Claims Hydrogen Peroxide SA (CDC) – has launched a suit in regional court of first instance for Dusseldorf, Germany, against six alleged members of an international hydrogen peroxide cartel that has already been the targetof landmark fines from the European Commission and multimillion dollar class action settlements in the U.S. Five of the six defendants of the present suit were fined in 2006 for their involvement in a price-fixing and market-allocating cartel for hydrogen peroxide and sodium perborbate. The sixth defendant received full immunity from the fines for providing information about the cartel under EC’s leniency program. The same companies also faced a large number of suits in the U.S. over the alleged price-fixing cartel, which have either settled or are awaiting settlement approval. In order to bring the current suit, CDC bought the rights to private damage claims, worth over € 430 million ($561 million), from 32 companies for hydrogen peroxide that they bought from the defendants during the cartel period. The claim-buying approach allows CDC to take on all the cost and risk of litigation.